CrowdStrike Falcon® Shield delivers industry-leading protection and control over SaaS misconfigurations, identities and threats – unifying hybrid identity protection
Today’s adversaries increasingly exploit identities and cloud environments as trusted entry points, as 79% of initial access attacks are now malware-free. These cross-domain attacks exploit complex hybrid environments and fragmented security tools that leave gaps in protecting on-premises Active Directory (AD), cloud-based identity providers and the growing landscape of SaaS applications. Falcon Shield provides best-in-class security posture management and threat protection across SaaS identities, misconfigurations and data. With Falcon Shield unifying into the Falcon platform, CrowdStrike can empower organizations to secure every part of modern hybrid environments – at every stage of the full attack lifecycle – from initial access to lateral movement, all through a single, unified platform.
“With Falcon Shield, CrowdStrike’s deep understanding of customer pain points and its ability to address the existing technology gap in the SaaS security space truly stand out,” said Ying Ting Neoh, industry analyst at Frost & Sullivan. “Its strategic alliances, along with its comprehensive and scalable SSPM solution, enhance customer support and lower total cost of ownership, providing long-term cost-effectiveness compared to market participants offering piecemeal solutions that lack integrations. These advantages have fostered a positive customer purchase, ownership, and service experience. This is a leading reason we also named CrowdStrike the leader in the 2024 Frost Radar™ for SaaS Security Posture Management.”
According to Frost & Sullivan’s authoritative report, CrowdStrike Falcon Shield stands out in the following areas:
Comprehensive SaaS Security: Falcon Shield secures more than 150 SaaS applications, protecting both human and non-human identities (NHI) from being exploited in an attack. With deep risk correlation between devices and SaaS applications, along with proactive misconfiguration management, organizations gain complete visibility and control over their SaaS environments.
Unified Hybrid Identity and Cloud Security: The powerful combination of Falcon Shield and Falcon® Identity Protection delivers proactive security and advanced identity threat detection and response (ITDR), securing every stage of identity-based attacks across every part of modern hybrid environments – from on-premises Active Directory to cloud-based identity providers like Microsoft Entra ID and Okta, and SaaS applications. The integration with CrowdStrike Falcon® Cloud Security will provide unified protection for cloud infrastructure, apps, data, AI models and SaaS all from a single console.
GenAI Security Control: Falcon Shield continuously monitors SaaS environments to detect configuration changes, prevent data leakage from misconfigured AI settings and uncover unauthorized AI applications. By enabling risk-based access controls, organizations can ensure AI tools are securely managed and aligned with enterprise security policies.
Automated SaaS Remediation: With Falcon Shield and Falcon Fusion SOAR, organizations can automate the remediation of high-risk misconfigurations, reducing risk exposure and maintaining compliance across SaaS environments. Bidirectional integrations into ticketing systems and step-by-step remediation guidance empowers security teams to resolve issues faster and more efficiently.
“SaaS applications are prime targets for today’s adversaries, and security teams can no longer rely on fragmented solutions to stay protected,” said Elia Zaitsev, chief technology officer, CrowdStrike. “With Falcon Shield, CrowdStrike delivers the industry’s most complete SaaS security posture management and threat protection while securing every area of modern hybrid environments, at every stage of the attack. Frost & Sullivan’s recognition of Falcon Shield reinforces our leadership in SSPM and our commitment to securing global organizations against evolving threats.”
Each year, Frost & Sullivan presents a Company of the Year award to the organization that demonstrates excellence in terms of growth strategy and implementation in its field. The award recognizes a high degree of innovation with products and technologies, and the resulting leadership in terms of customer value and market penetration.
Frost & Sullivan Best Practices awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.
About Frost & Sullivan For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.
TOKYO and SANTA CLARA, Calif, March 10, 2025 /PRNewswire/ — Plus, a global leader in AI-based autonomous trucking software, and TIER IV, the pioneering force behind the world’s first open-source software for autonomous driving, today announced a strategic partnership to accelerate the development and deployment of advanced autonomous driving solutions, Autonomy 2.0, in Japan, starting with Level 4 autonomous trucks on Japan’s expressways. The collaboration supports a Japanese government-led initiative to expedite the development of autonomous driving technologies, aimed at addressing the country’s critical driver shortage.
As part of the collaboration, Plus and TIER IV will co-create a customized autonomous driving software solution for the Japan market by integrating Plus’s end-to-end virtual driver AI model with TIER IV’s platform based on Autoware*, open-source software for autonomous driving championed by TIER IV.
TIER IV’s CEO Shinpei Kato said: “We’ve always believed that co-creation with our partners is the fastest way to bring the best autonomous driving systems to the world. Plus is a global autonomous driving software company that’s already powering the Level 4 autonomous trucks of leading truck makers in the United Statesand Europe like TRATON GROUP’s Scania, MAN and International, Iveco Group, as well as Hyundai. This makes Plus the ideal partner to accelerate deployment of Autonomy 2.0-based autonomous driving technology in Japan, starting with autonomous trucks.”
“Driverless trucks are a necessary solution to address Japan’s acute truck driver shortage and aging population,” said David Liu, CEO and Co-Founder of Plus. “We are excited to leverage our AV2.0 Generative AI-based autonomous driving technology and expertise in deploying autonomous trucks with global truck makers to work with TIER IV to accelerate the rollout of driverless trucks in Japan.”
A study by the Nomura Research Institute projected a 36% shortfall in truck drivers in Japan by 2030. To address this challenge, Plus and TIER IV are joining forces, leveraging TIER IV’s experience and proven track record in the Ministry of Economy, Trade and Industry (METI) project to develop autonomous trucks based on vehicles from Japanese vehicle manufacturers. Through the collaboration, the companies will pave the way for more innovative and efficient freight transport for the Japanese market.
*Autoware is a registered trademark of the Autoware Foundation.
TAIPEI, March 10, 2025 /PRNewswire/ — Ubiqconn Technology, a leading provider of industrial Internet of Vehicle (IoV) and embedded Internet of Things (IoT) solutions, is excited to announce its participation at Satellite 2025 in Washington DC, from March 11th to 13th. As one of the industry’s premier events, Satellite 2025 provides an unparalleled platform for discovering the latest advancements in satellite technology, connecting with industry leaders, and engaging in conversations that are shaping the future of satellite communications.
Ubiqconn Joins Satellite 2025 to Showcase Cutting-Edge Satellite Communication Solutions
Ubiqconn will be showcasing its state-of-the-art solutions tailored to enhance connectivity, efficiency, and reliability across various industries such as maritime, logistics, port management, and remote operations. With its innovative products and services, Ubiqconn aims to revolutionize satellite communication systems and expand their capabilities to meet the evolving demands of global markets.
“We are thrilled to participate in Satellite 2025, as it presents an exciting opportunity to connect with industry pioneers, showcase our latest innovations, and explore new ways to push the boundaries of satellite communication technology,” said Tim Tsai, North America CEO at Ubiqconn and RuggON. “We look forward to demonstrating our contributions to the industry and discussing how Ubiqconn is driving the future of satellite connectivity.”
Visit Ubiqconn at Booth #2343 in the Taiwan Space Pavilion.
Satellite 2025 will gather experts, key stakeholders, and thought leaders from the satellite and space sectors. The event will feature a range of presentations, panel discussions, and networking opportunities, addressing the most pressing challenges and opportunities within the satellite industry.
About Ubiqconn
Ubiqconn is a subsidiary of the FIC Group, a leader in global high-tech design, engineering, and manufacturing for over 40 years. Given this experience, Ubiqconn’s professional team also provides high-quality assurance in ODM and OEM products. Ubiqconn is an innovative manufacturing company that specializes in the industrial Internet of Vehicle (IoV) solutions and embedded Internet of Things (IoT) solutions With a perfect balance between technology and application know-how, Ubiqconn can achieve the customer demand to conquer the increasing challenge in IoT. For more information, visit http://www.ubiqconn.com or follow us on LinkedIn
About RuggON
RuggON Corp. is a a subsidiary of Ubiqconn Technology and a leading manufacturer of rugged mobile computing solutions. Combining Ubiqconn’s advanced technology to drive innovation and expand in the Mobile Industrial (IioT) market. With decades of ruggedized mobile solution expertise, RuggON strives to improve mobile productivity in harsh environments. A committed engineering team delivers devices of exceptional value and quality that improve user experience. The company is dedicated to understanding the various demands of different industries in order to provide application-oriented, tailored solutions that are efficient and effective. RuggON is committed to higher standards to achieve customer satisfaction. It prides itself on providing endless possibilities today to meet the demands of tomorrow. For more information, visit our website http://www.ruggon.com or follow us on LinkedIn.
HONG KONG SAR – Media OutReach Newswire – 10 March 2025 – The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.
Highlights
30% growth in underlying profit to US$201 million
Health and Beauty delivered a stable performance
Convenience saw strong profit growth due to favourable product mix
Food profit improved, driven by significant Singapore Food earnings recovery
Portfolio simplification progressed further with Yonghui and Hero Supermarket divestments
Net cash position achieved in February 2025 with completion of Yonghui sale
Final dividend of US¢7.00 per share
“Effective strategy execution led to strong underlying profit growth in 2024, despite a challenging retail environment. We aim to remain relevant to consumers and to increase market share further, by evolving our offering through leveraging data and expanding our omnichannel presence. We are well-positioned for sustainable growth and increased shareholder returns over the mid-term.”
John Witt Chairman
PRELIMINARY ANNOUNCEMENT OF RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024
PERFORMANCE I am pleased to report that DFI Retail Group (‘DFI’ or the Group) delivered a significantly improved underlying performance and a good partial recovery in results in 2024, despite a challenging retail environment. For the full year, underlying profit attributable to shareholders reached US$201 million, a 30% increase from the previous year.
Our diverse portfolio and effective operational execution enabled us to gain market share across key businesses, even as we faced shifts in consumer behaviour and macroeconomic headwinds. Profit growth was driven by improved profit in Food and Convenience, supported by growth in digital channels.
We are confident that the Group’s new strategy will drive further profit growth in the coming years, and are particularly optimistic about the growth prospects for our Health and Beauty business, which represents 55% of the Group’s total operating profit. We also see strong growth opportunities in our Convenience business. Our other businesses continue to face challenges, but we are confident in the ability of DFI’s senior leadership team to navigate short-term uncertainties, evolve the portfolio and invest in strengthening our core businesses to drive long-term growth in shareholder value.
The Board recommends a final dividend for 2024 of US¢7.00 per share (2023 final dividend: US¢5.00).
STRATEGIC HIGHLIGHTS Under the capable leadership of our Group Chief Executive, Scott Price, we have made significant strides in implementing our strategic framework, which centres around three core pillars:
Customer First Across our business, we have an ongoing commitment to putting our customers first, and we have made significant progress to better serve them over the past year. The yuu Rewards loyalty programme continues to strengthen, with a substantial increase in members and the addition of a number of further partners. We have also begun harnessing our proprietary customer data to refine our product assortment and revamp our Own Brand and digital strategies. We are driving a more transparent and collaborative approach to our negotiations with suppliers, leading to a better outcome for customers. As well as better serving our customers, these efforts aim to bolster market share growth and enhance margins across our businesses.
People Led We have refined our organisation structure over the past year. Our new senior leadership team, with its deep industry expertise, shares a vision for strategic growth and operational excellence. Key appointments across the business have strengthened our capability to drive these initiatives forward, and we have reduced spans and layers within the organisation to streamline operations and expedite decision-making. Diversity across our business has also improved significantly.
Shareholder Driven In alignment with our strategic and capital allocation priorities, we continued to simplify the Group’s portfolio and divested our Hero Supermarket business and investment in Yonghui Superstores.
Following the disposal of Hero Supermarket, the Guardian and IKEA businesses will be our focus in Indonesia and we are confident in the long-term prospects for these two businesses to increase market share as the Indonesian market grows. These disposals allow us to reinvest in our subsidiaries’ growth, deleverage our balance sheet and grow total shareholder returns.
Sustainability remains at the top of our agenda, and we are collaborating closely with our stakeholders and setting ambitious targets across the business. There was strong progress in 2024 against the Group’s sustainability strategy in areas including emissions reduction and waste diversion. Our efforts were recognised in improvements in our ESG ratings, including a significant improvement in the Group’s S&P Global Corporate Sustainability Assessment. We will continue to promote and drive sustainable business practices in our end-to-end value chain.
GOVERNANCE AND PEOPLE The Board and its Committees, and senior leadership team, together play a key role in delivering against our priorities. The effective execution of our strategy depends on high quality debate around the boardroom table, with strong contributions from all Directors.
There have been a number of significant Board and executive leadership changes since the start of 2024:
– In July, I succeeded Ben Keswick as Chairman. On behalf of the Board, I would like to express our gratitude to Ben for his 11 years of service as Chairman.
– I also wish to thank Adam Keswick for his contribution to the Board and Nominations Committee as he steps down.
– We welcomed Elaine Chang to the Board as an Independent Non-Executive Director and Graham Baker as a Non-Executive Director. Elaine has 30 years of leadership experience across industries such as semiconductors, digital content, e-commerce, cloud computing and artificial intelligence, and her expertise in leveraging technology to drive growth will greatly benefit the Group.
– Christian Nothhaft was appointed as a member of the Remuneration and Nominations Committees.
– Tom van der Lee took over as Group Chief Financial Officer from Clem Constantine. We thank Clem for his significant contribution, especially during the pandemic and in strengthening the Group’s financial position. Tom, who joined DFI in 2016, brings a wealth of experience from his various senior financial roles within the organisation.
– Sean Ward succeeded Jonathan Lloyd as our Company Secretary in December 2024. I want to thank Jonathan for his years of valued service.
PROSPECTS We are pleased by the Group’s strong underlying profit growth in 2024, despite a challenging retail backdrop, providing encouraging early support for our new strategy. We aim to consolidate our position in markets such as Hong Kong where we have strong businesses, while at the same time aiming to achieve long-term growth as we expand key businesses such as Health and Beauty and Convenience.
By evolving our offerings through data-driven insights and expanding our omnichannel presence, we will remain relevant to consumers and continue capturing market share. Our deleveraged balance sheet and strategic initiatives position us well for sustainable growth and increased shareholder returns in the years to come.
I should like to express my appreciation to our shareholders, our valued partners and to the wider community for your continued support. Most of all, thanks must go to our team members, who are key to our success, for their exceptional work and unwavering commitment throughout the past year, despite challenging market conditions.
John Witt Chairman
GROUP CHIEF EXECUTIVE’S REVIEW
INTRODUCTION As I reflect on my first full year as DFI’s Group Chief Executive, I am incredibly proud of the significant progress we have made executing in alignment to our strategic framework: Customer First, People Led, Shareholder Driven.
Despite the challenging macroeconomic backdrop, we demonstrated resilience in our business performance, reporting underlying profit attributable to shareholders of US$201 million in 2024, up 30% year-on-year. During the year, we announced the divestment of our minority stake in Yonghui, a transaction that aligns with our strategic and capital allocation framework and enables us to reinvest in the future growth of our subsidiary businesses. While our reported results were impacted by one-off items, including fair value loss, impairment of equity interest and goodwill, we have continued to significantly deleverage our balance sheet with a net cash position following the completion of the Yonghui transaction in February 2025.
As we head into the new financial year, we remain laser focused on executing our strategic priorities to drive revenue growth and enhance profitability. Our 2025 financial guidance of US$230 million to US$270 million underlying profit attributable to shareholders, reflects our confidence in further building on our momentum and delivering greater value for our stakeholders.
STRATEGIC FRAMEWORK – KEY PROGRESS We developed our strategic framework of Customer First, People Led, Shareholder Driven in the second half of 2023 to guide the Group’s capital allocation priorities and growth plans over the coming years. I am both pleased and proud of the progress made by the team over the past 12 months in executing on this framework.
Customer First I continue to see value unlock across our uniquely diverse businesses across Asia. We are proud to serve millions of customers in various formats and banners with nearly 11,000 outlets across 13 markets in Asia. What stands out is our ongoing commitment to putting our customers first and serving with passion and care. Our purpose has always been part of who we are. During the year, we launched our DFI purpose to articulate it in a way that unites our organisation, which is to Sustainably Serve Asia for Generations with Everyday Moments. This statement underscores our commitment to meeting the everyday needs of our customers across Asia, while emphasising their interests in sustainable solutions.
Aligned with our purpose, we have made significant progress in a number of areas to better serve our customers over the past year.
yuu Rewards Our yuu Rewards coalition loyalty programme continues to strengthen. In our home market of Hong Kong, total members have reached 5.3 million with over 3 million monthly active members. The active use of purchases across all our formats, restaurants and partners creates substantial volume of unique data insights. In 2024, the yuu Rewards programme in Hong Kong added a number of additional partners including Starbucks and FWD Insurance. Our members have engaged across a variety of redemption offers that incorporate new travel, entertainment and dining options, driving enhanced customer engagement.
In Singapore, the yuu Rewards programme has grown to over 1.8 million members. A number of new partners joined the programme during the year including Suntec City and Singapore Airlines.
Improving assortment We are now leveraging our broad yuu Rewards customer data to improve assortment in our stores. At Wellcome, we have leveraged our proprietary data and cutting-edge data analytics capabilities to execute a reset of 14 categories in stores. The improved assortment has seen very encouraging initial results with uplifts in both sales and gross profits. We are now also leveraging the learnings from Wellcome to support assortment optimisation for our Health and Beauty and Convenience businesses across Hong Kong and Singapore.
Improving supplier collaboration We are beginning to better leverage our data to support enhanced supplier collaboration. By creating a more transparent and collaborative approach to negotiations with suppliers, we are working together to drive market growth and a better outcome for customers.
Own Brand We have reset our Own Brand strategy to better align with customer needs while delivering stronger margins for our business. By optimising our product range, redesigning packaging for greater customer appeal and maximising cross-selling opportunities across our formats, we have made meaningful improvements in margin and sales productivity, which includes a more than 300bps increase in our Food Own Brand margin and close to a 40% increase in sales productivity compared to 2023. Following the success of our reset of the Own Brand portfolio across our Food business, we have integrated the Health and Beauty Own Brand assortment into this center of excellence to replicate the same success in Health and Beauty as we reset its private label strategy.
Digital Following our digital strategy reset in September 2023, customers are now able to access our retail portfolio through a wider range of digital assets including apps, websites and third-party platforms. Our expanded omnichannel presence includes Wellcome’s quick-commerce partnership with foodpanda, a new 7-Eleven app with approximately 137,000 monthly active users and 30,000 daily active users in Hong Kong as of December 2024. Including a new Mannings Hong Kong app and Guardian Singapore app, we have launched more than 20 new channels in 2024 across apps, websites and third-party platforms. Our strengthened digital proposition was underpinned by a 31% growth in e-commerce order volume with strong profitability turnaround.
Retail Media DFI launched our own Retail Media network in the first quarter of 2024. Initial performance has been encouraging, with more than 100 targeted marketing campaigns sold in less than a year since the launch, supported by strong sales acceleration in the second half. We have partnered with leading suppliers such as Procter & Gamble, Unilever, Coca-Cola, Nestlé and Reckitt. Importantly, the integrated online and offline advertising proposition for Retail Media has supported the improved Return on Ad Spend for our supplier partners. We are in the early days of a potentially significant source of profit to invest in the business.
People Led In alignment with our strategic framework, we refined our organisation structure in the second half of 2023 by moving accountability to a format structure, thereby improving agility while reducing overhead costs. Throughout 2024, we have been focused on deeply embedding our values, underpinned by our purpose statement across the Group. We have reduced spans and layers within the organisation to streamline operations and expedite decision making. Diversity representation across formats has been significantly improved to ensure local relevancy of decision-making to customers. We have strengthened our leadership succession planning and development with a meaningfully improved team member engagement score, supported by a new incentive structure for senior management that aligns with shareholder interests, based on total shareholder return and business performance targets.
Shareholder Driven Our strategic framework has been developed with the primary aim of improving shareholder returns. We have approached capital allocation in a disciplined manner, both from a capex and working capital management perspective. Over the course of the year, we executed the divestment of a number of company-owned properties, which has supported a US$150 million reduction in net debt at the end of 2024.
Concurrently, the Group continues to execute M&A transactions in a manner that is accretive to return on capital and total shareholder return based on a strategic review of our businesses in 2024. In June 2024, the Group completed the divestment of the Hero Supermarket business in Indonesia. Post-completion, DFI’s operations in Indonesia has fully pivoted to the Guardian and IKEA businesses. In September 2024, the Group announced the divestment of its entire stake in Yonghui Superstores Co., Ltd. This transaction was subsequently completed in February 2025. The Group is in a net cash position following the completion of the Yonghui transaction.
2024 PERFORMANCE The Group reported total revenue from subsidiaries in 2024 of US$8.9 billion, down 3% year-on-year. However, excluding the impact of a significant tobacco tax increase in Hong Kong, the divestment of our Malaysia Food business in 2023 and Hero Supermarket operation in Indonesia, operating revenue was largely stable. This broadly represents market share gains in all formats except IKEA.
Total revenue for the Group, including 100% of associates and joint ventures, was US$24.9 billion, down 6% compared to 2023, largely due to lower sales at Yonghui. Total underlying profit attributable to shareholders was US$201 million for the year, up 30% year-on-year.
The Group reported subsidiaries underlying profit attributable to shareholders of US$158 million for the full year, 42% higher than the prior year. This was driven by significant earnings recovery in Singapore Food and favourable product mix shift towards non-cigarette categories in our Convenience business, partially offset by lower contribution from Home Furnishings as a result of weak property market activity and intensifying competition.
The Group’s share of underlying profit from associates was US$43 million, down 2% year-on-year. Lower contribution from Maxim’s due to weaker mooncake sales and restaurant performance in the Chinese mainland was partially offset by reduced losses from Yonghui and a 15% profit growth at Robinsons Retail.
The Group’s reported results for the year were impacted by non-trading losses attributable to shareholders of US$445 million. This was predominantly due to loss of US$114 million associated with the divestment of Yonghui, a US$231 million impairment of interest in Robinsons Retail and US$133 million goodwill impairment of Macau and Cambodia Food businesses. These losses were partially offset by gains from divestment of Singapore property assets and the Group’s share of one-off gains from the Bank of the Philippine Islands (BPI)-Robinsons Bank merger. Despite the large non-trading losses reported, the Group is now in a net cash position following the completion of Yonghui transaction in February 2025.
The Group reported operating cash flow after lease payments of US$331 million, 21% lower than the prior year, mainly due to unfavourable movement in working capital year-end timing difference, partially offset by underlying operating profit growth. Operating cash flow after lease payments and normal capital expenditure was US$158 million, down 29% year-on-year.
ENVIRONMENTAL, SOCIAL, GOVERNANCE (ESG) As a leading Asian retailer, we recognise our unique opportunity to promote and drive sustainable business practices in response to the preference of our customers. By positioning our ESG commitment as a core pillar of our Group Strategy, we have made meaningful progress in various initiatives, including emissions reduction and waste diversion. Our efforts are reflected in a significant improvement in the S&P Global Corporate Sustainability Assessment, with our score improving to 49 as at 8 January 2025, placing DFI in the 84th percentile within the Food and Staples Retailing industry, up from the 47th percentile in 2023.
Our strong commitment to ESG is underscored by our target to halve Scope 1 & 2 greenhouse gas (GHG) emissions by 2030 and achieve net-zero by 2050. Throughout 2024, we have made significant investments in upgrading and converting our existing refrigeration systems to more environmentally friendly options. We successfully completed trials of natural gas and ultra-low global warming potential gases as refrigerant alternatives for our food stores. Following a comprehensive analysis of our Scope 3 emissions, we have identified key product categories and realistic decarbonisation opportunities within our supply chain. For example, our Low Carbon Rice Project, launching in Thailand this year, aims to drive decarbonisation by promoting low-carbon farming practices among local farmers, implementing field monitoring and tracking to measure carbon emission reductions. We have made notable progress in improving our waste diversion and are constantly exploring innovative ways to foster a transition towards a local circular economy. Wellcome has partnered with a Hong Kong-based recycling facility to convert trimmed fats into biodiesel for powering essential generators.
While we are still early in the journey, these initiatives collectively demonstrate our efforts and commitment to serving communities sustainable and affordable products, sustaining the planet and sourcing responsibly while meeting the return objectives of our shareholders.
BUSINESS REVIEW
HEALTH AND BEAUTY Sales for the Health and Beauty division came in slightly higher than the prior year at US$2.5 billion, with like-for-like (LFL) sales remaining broadly stable. Underlying operating profit was US$211 million for the year, slightly below 2023.
Hong Kong reported strong LFL sales performance in the first quarter, which then decelerated in the second and third quarters due to a strong comparable period in 2023 when consumption vouchers were disbursed in April and July 2023. Sales momentum improved in the fourth quarter with Mannings continuing to gain market share. Profit for the year increased 6%, attributable to gross margin improvement and disciplined cost control, despite a 2% decline in full-year LFL sales. Guided by a customer-first proposition, the Pharmacare programme reached a significant milestone since its launch in 2023. In partnership with Bupa, one of Hong Kong’s major medical insurers, the Mannings team further expanded Pharmacare into its network of more than 150,000 members. Leveraging Mannings’ position as the largest pharmacist network, the programme offers free consultations and medication for a range of common illness. The Mannings team continued to enhance in-store experience with the launch of the Health Pod at our International Finance Centre flagship store in Hong Kong. This innovative service offers an AI wellness assessment that measures over 20 metrics, followed by personalised consultations and product recommendations. Initial results have been promising, with customers using the service showing a basket size three times higher than average. In addition, the team also launched a new Mannings app in December to grow its digital footprint. LFL sales of Mannings China declined as the business pivots away from offline stores to online channels which involves the closure of the majority of its offline network.
Guardian in South East Asia reported US$857 million in sales, reflecting a 5% year-on-year increase, driven by growth in basket size across all key markets. Indonesia, in particular, saw a 17% LFL sales growth supported by increased mall traffic and strong execution of promotional campaigns. Strong profit growth was reported across most key markets, underpinned by gross margin expansion and operating leverage. In Singapore, strong commercial execution and a favourable product mix contributed to gross margin expansion, with healthcare products accounting for more than 60% of sales.
CONVENIENCE Total Convenience sales were US$2.4 billion, representing a decline of 3% year-on-year. LFL sales were 5% behind the prior year, impacted by a decline in lower-margin cigarette volumes following tax increases in Hong Kong at the end of February 2024. Excluding cigarette sales, overall Convenience LFL sales were up 2%, with continued market share gain across markets. Convenience underlying operating profit was US$102 million for the year, an increase of 17% compared to 2023. Hong Kong operating profit has grown 10% year-on-year, driven by a favourable mix shift towards higher-margin categories, with ready-to-eat (RTE) accounting for 16% of total sales for the full year. The newly launched 7-Eleven app offers discounted RTE bundles, pre-order functions, and digital stamps for IP collectibles to drive purchase frequency and customer loyalty.
7-Eleven South China and Singapore reported largely stable LFL sales supported by robust growth in RTE, which accounted for 40% and 23% of sales, respectively. Favourable margin impact from product mix shift and ongoing cost control contributed to meaningful profit growth in both markets. 7-Eleven continued to grow its store network in the South China region with 103 net openings during the year. The Group aims to drive further network expansion primarily through a capex-light franchise model.
FOOD Reported sales for the Food division in 2024 were US$3.1 billion, down 5% year-on-year. Excluding the impact of the divestment of the Malaysia Food business in 2023 and Hero Supermarket operation in Indonesia, revenue for the division was 2% lower than the prior year. Underlying operating profit for the division was US$58 million for the year, up from US$45 million in 2023.
While increased outbound travel of Hong Kong residents to the Chinese mainland has affected food consumption for the majority of 2024, the situation has begun to normalise with total retail sales of supermarkets in Hong Kong returning to growth in the fourth quarter of 2024. Wellcome saw improving sales momentum in the fourth quarter with full-year LFL sales marginally below those of the prior year despite challenging trading conditions. Strong in-store execution and effective promotional campaigns have supported consistent market share gain over the course of the year. The Wellcome team has strengthened its omnichannel presence through the wellcome.com.hk website, its app and a quick-commerce partnership with foodpanda, contributing to a more than 20% sales growth in overall Food e-commerce with significantly improved profitability.
South East Asia Food sales performance was adversely affected by intense competition and soft consumer sentiment due to cost-of-living pressures. Improved sales mix, effective cost control and optimisation of the store portfolio led to a meaningful earnings recovery, with Singapore Food turning profitable in the fourth quarter of 2024. The Group continues to serve the Singapore market with different propositions through its various brands.
In June 2024, the Group completed the divestment of its Hero Supermarket business in Indonesia. Post-completion, DFI’s operations in Indonesia have fully pivoted to the Guardian and IKEA businesses.
HOME FURNISHINGS IKEA reported sales of US$701 million, representing a 12% drop compared to the prior year. Overall, LFL sales reduced by 11% in 2024. Operating profit was US$16 million, down 13% year-on-year.
IKEA’s business performance has been hampered by reduced customer traffic due to weak property market activity across regions. While IKEA Taiwan demonstrated relative resilience, sales in Hong Kong and Indonesia were affected by intensified competition and basket mix change as customers reduced purchases of big-ticket items.
In response to the challenging sales environment, the IKEA team continues to implement strong cost control measures across our markets. The IKEA Hong Kong business is pivoting towards a more value-driven omnichannel proposition to compete with Chinese mainland digital platforms. E-commerce penetration has now surpassed 10% across all markets. The IKEA Indonesia team remains focused on driving sales through enhancing store commerciality, increasing local sourcing, and adopting a more effective marketing strategy to improve local relevancy. Implementation of cost-saving measures contributed to narrowing losses compared to the prior year.
RESTAURANTS The Group’s share of Maxim’s underlying profits was US$66 million in 2024, down from US$79 million in the prior year, largely due to lower mooncake sales and weaker restaurant performance on the Chinese mainland. Maxim’s continued to expand its presence in South East Asia, adding 76 net new stores during the year, mainly in Thailand and Vietnam. Benefiting from a diversified portfolio, restaurant sales performance in Hong Kong remained resilient despite an increase in outbound travel on weekends and public holidays.
OTHER ASSOCIATES The Group’s share of Yonghui’s underlying losses was US$33 million for the year, compared to a US$36 million share of underlying losses in the prior year. Continued macro headwinds and intense competition led to lower LFL sales. The reduction in losses was underpinned by ongoing cost optimisation, partially offset by a decline in gross margin. The divestment of the Group’s minority stake in Yonghui was completed in February 2025.
Robinsons Retail’s underlying profit contribution was US$17 million, up 15% year-on-year. Robinsons Retail reported low single-digit growth in LFL and robust growth in operating profit driven by the Food and Drugstore segments. Reported profit contribution grew close to 90% year-on-year, supported by one-off gains following the BPI-Robinsons Bank merger in early 2024.
OUTLOOK We have navigated 2024 with resilient business performance and continued market share gains for our key business units by proactively adapting to changing market conditions through a stronger value proposition, expanded omnichannel presence and disciplined cost control. While challenges remain, we are cautiously optimistic about the outlook for 2025. The Group expects underlying profit attributable to shareholders to be between US$230 million and US$270 million in 2025, supported by an organic revenue growth of approximately 2%.
The Group will continue to execute against its strategic framework. By enhancing the local relevancy of our product offerings, deepening monetisation of our digital assets, and executing value-enhancing M&A transactions, we have put in place solid foundations in 2024, and we remain confident in driving sustained, profitable growth and shareholder returns in the years ahead.
Scott Price Group Chief Executive Hashtag: #DFIRetailGroup #Mannings #Guardian #7-Eleven #Wellcome #MarketPlace #ColdStorage #Giant #IKEA #yuuRewards #Maxim’s #RobinsonsRetail
The issuer is solely responsible for the content of this announcement.
DFI Retail Group
DFI Retail Group is a leading Asian retailer. At 31 December 2024, the Group, its associates and joint ventures operated over 10,700 outlets, of which more than 5,000 stores were operated by subsidiaries. The Group, together with associates and joint ventures, employed over 190,000 people, with over 45,000 people employed by its subsidiaries. The Group had total annual revenue in 2024 of US$24.9 billion and reported revenue of US$8.9 billion.
DFI Retail Group is dedicated to delivering quality, value and exceptional service to Asian consumers through a compelling retail experience, supported by an extensive store network and highly efficient supply chains.
The Group (including associates and joint ventures) operates a portfolio of well-known brands across six key divisions. The principal brands are:
Health and Beauty
Mannings on the Chinese mainland, Hong Kong and Macau S.A.R.; Guardian in Brunei, Indonesia, Malaysia, Singapore and Vietnam.
Convenience
7-Eleven in Hong Kong and Macau S.A.R., Singapore and Southern China.
Food
Wellcome and Market Place in Hong Kong S.A.R.; Cold Storage and Giant in Singapore; Lucky in Cambodia; and Robinsons in the Philippines.
Home Furnishings
IKEA in Hong Kong and Macau S.A.R., Indonesia and Taiwan.
Restaurants
Hong Kong Maxim’s group on the Chinese mainland, Hong Kong and Macau S.A.R., Cambodia, Laos, Malaysia, Singapore, Thailand and Vietnam.
Other Retailing
Robinsons in the Philippines operating department stores, specialty and DIY stores.
At the heart of its business, DFI Retail Group is driven by its purpose to ‘Sustainably Serve Asia for Generations with Everyday Moments’.
The Group’s parent company, DFI Retail Group Holdings Limited, is incorporated in Bermuda and has a primary listing in the equity shares (transition) category of the London Stock Exchange, with secondary listings in Bermuda and Singapore. The Group’s businesses are managed from Hong Kong. DFI Retail Group is a member of the Jardine Matheson Group.
“Eradicating Hypertension” Explores How Oxygen Intake and Breathing Optimization Can Transform Blood Pressure Management
NEW YORK, USA – Media OutReach Newswire – 10 March 2025 – Hypertension remains one of the leading health concerns in the United States, affecting nearly half of all adults and contributing to heart disease, stroke, and kidney failure. However, a groundbreaking new book, Eradicating Hypertension: How Patient K Accidentally Got Rid of High Blood Pressure, is shifting the conversation by introducing a science-backed yet unconventional approach to blood pressure management—one that focuses on oxygen intake, breathing, and sleep therapy.
Published by POV Publish, this book tells the true story of Patient K, a former hypertension patient who—despite decades of medication—found a surprising and effective solution by improving his breathing efficiency and oxygen levels using a BiPAP-assisted breathing device. His journey, documented with medical insights and real data, suggests that hypertension may not be a lifelong condition, but one that can be dramatically improved—or even reversed—with the right approach.
Unlike conventional hypertension treatments that primarily focus on medication and diet, Eradicating Hypertension explores the critical but overlooked connection between breathing, sleep quality, and cardiovascular health. The book explains how:
Oxygen intake plays a vital role in blood pressure regulation
Sleep apnea and low SpO2 (oxygen saturation) can silently worsen hypertension
Breathwork and assisted breathing devices (such as BiPAP) improve oxygen levels, reducing the need for medication
A holistic, patient-led approach can complement traditional treatments and provide new hope for millions
The release of Eradicating Hypertension comes at a critical time in the United States, where:
47% of adults have high blood pressure, yet many are unaware of alternative solutions.
Sleep apnea affects an estimated 30 million Americans, but the link between low oxygen and hypertension remains under-discussed.
Breathwork and assisted breathing therapies are gaining traction in the U.S. wellness space, making this book a timely and valuable resource.
Estina Tan, Publisher at POV Publish, said: “For decades, hypertension has been treated as a condition that requires lifelong medication. But what if we’ve been overlooking something as simple as the way we breathe? Patient K’s journey shows that breathing optimization can dramatically impact blood pressure. This book aims to educate, empower, and change lives.”
Eradicating Hypertension is now available on Amazon, with an eBook, hardcover and paperback editions. Readers can also access additional resources by scanning the QR code in the book, including podcasts, illustrations, recommended products and extended chapters. Hashtag: #POVPublish
The issuer is solely responsible for the content of this announcement.
ABOUT POV PUBLISH
POV Publish is an independent publishing house dedicated to bringing exclusive point-of-view stories to the world. We focus on blending real-life experiences, medical insights, and practical solutions to empower individuals to take control of their health.
ABOUT PATIENT K
Patient K is the author of Eradicating Hypertension, a book documenting a real-life transformation in blood pressure management. His journey, validated by medical experts, highlights the power of breathing, sleep optimization, and oxygen therapy in cardiovascular health.
CHENGDU, China, March 10, 2025 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”) announced that the Company’s trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, formerly SKB264/MK-2870) was approved for marketing by the National Medical Products Administration (NMPA) for the second indication which is for the treatment of adult patients with epidermal growth factor receptor (EGFR) mutant-positive locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) following progression on EGFR-tyrosine kinase inhibitor (TKI) therapy and platinum-based chemotherapy. This is the first TROP2 ADC drug approved for marketing in lung cancer globally. Compared with current standard of care, sac-TMT significantly extents the overall survival benefits of these patients.
The approval is based on a multi-center, randomized, controlled, pivotal study (OptiTROP-Lung03) that evaluates the efficacy and safety profile of sac-TMT monotherapy 5mg/kg every other week (Q2W) as an intravenous injection versus docetaxel for the treatment of patients with locally advanced or metastatic EGFR-mutant NSCLC who have failed after treatment with an EGFR-TKI and platinum-based chemotherapy (used sequentially or in combination). As demonstrated in a pre-specified interim analysis, sac-TMT monotherapy demonstrated a statistically significant and clinically meaningful improvement in objective response rate (ORR), progression-free survival (PFS) and overall survival (OS) compared with docetaxel.
Sac-TMT is also the first ADC drug to demonstrate a statistically and clinically significant improvement in overall survival benefit versus standard of care in patients with EGFR-mutant NSCLC after failure of EGFR-TKI and platinum-based chemotherapy.
Previously, the NMPA has approved the marketing of sac-TMT in China for adult patients with unresectable locally advanced or metastatic triple negative breast cancer (TNBC) who have received at least two prior systemic therapies (at least one of them for advanced or metastatic setting) and accepted a supplemental new drug application (sNDA) seeking the approval of sac-TMT monotherapy for patients with EGFR-mutant NSCLC who have failed after EGFR-TKI therapy.
Currently, sac-TMT is fully deployed in the NSCLC field, and Merck Sharp & Dohme and the company are conducting a total of 10 registrational Phase Ⅲ clinical studies in NSCLC globally and in China, with the threads covering from the late backline to early postoperative adjuvant, including monotherapy and combination studies. Among them, a registrational Phase Ⅲ clinical study has been conducted in China in combination with osimertinib for the first-line treatment of locally advanced or metastatic NSCLC with EGFR mutations (OptiTROP-Lung07).
Dr. Michael Ge, CEO of Kelun-Biotech said, “We are very pleased that the second indication of the Company’s TROP2 ADC sacituzumab tirumotecan has been approved for marketing, which is exciting progress for us in the field of lung cancer. The successful approval of this new indication will help to address an unmet treatment need for patients with later-stage EGFRm NSCLC in China. Kelun-Biotech has always been committed to promoting innovation and leadership, and we look forward to continuing our research in the field of ADCs in partnership with MSD.”
About NSCLC
Lung cancer, the second most common cancer in the world, includes two main types of cancer: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC is the most common pathological type, accounting for about 80 to 85% of all lung cancers. The molecular typing of NSCLC patients in China is different from that of Western populations, and EGFR mutation is a common variant gene type, accounting for about 40 to 50% of lung adenocarcinoma patients in China. According to the 2024 Chinese Journal of Cancer Research (CSCO) guidelines, EGFR-TKIs are the preferred treatment for stage IV EGFR-mutant NSCLC.1 Platinum-containing chemotherapy is the main first-line chemotherapy regimen after resistance to EGFR-TKIs; and existing treatment regimens are ineffective in those who have failed EGFR-TKIs and platinum-containing chemotherapy. New drugs are urgently needed to improve patient survival.
About sac-TMT (佳泰莱®)
Sac-TMT, a core product of the Company, is a novel human TROP2 ADC in which the Company has proprietary intellectual property rights, targeting advanced solid tumors such as NSCLC, breast cancer (BC), gastric cancer (GC), gynecological tumors, among others. Sac-TMT is developed with a novel linker to conjugate the payload, a belotecan-derivative topoisomerase I inhibitor with a drug-to-antibody-ratio (DAR) of 7.4. Sac-TMT specifically recognizes TROP2 on the surface of tumor cells by recombinant anti-TROP2 humanized monoclonal antibodies, which is then endocytosed by tumor cells and releases KL610023 intracellularly. KL610023, as a topoisomerase I inhibitor, induces DNA damage to tumor cells, which in turn leads to cell-cycle arrest and apoptosis. In addition, it also releases KL610023 in the tumor microenvironment. Given that KL610023 is membrane permeable, it can enable a bystander effect, or in other words kill adjacent tumor cells.
In May 2022, the Company licensed the exclusive rights to MSD (the tradename of Merck & Co., Inc., Rahway, NJ, USA) to develop, use, manufacture and commercialize sac-TMT in all territories outside of Greater China (includes Mainland China, Hong Kong, Macau, and Taiwan).
About Kelun-Biotech
Kelun-Biotech(6990.HK)is a holding subsidiary of Kelun Pharmaceutical (002422.SZ), which focuses on the R&D, manufacturing, commercialization and global collaboration of innovative biological drugs and small molecule drugs. The company focuses on major disease areas such as solid tumors, autoimmune, inflammatory, and metabolic diseases, and in establishing a globalized drug development and industrialization platform to address the unmet medical needs in China and the rest of world. The Company is committed to becoming a leading global enterprise in the field of innovative drugs. At present, the Company has more than 30 ongoing key innovative drug projects, of which 3 projects have been approved for marketing, 1 project is in the NDA stage, and more than 10 projects are in the clinical stage. The company has established one of the world’s leading proprietary ADC platforms, OptiDC™, and has 1 ADC project approved for marketing, 1 ADC project in NDA stage, and multiple ADC or novel ADC projects in clinical or preclinical research stage. For more information, please visit https://kelun-biotech.com/.
Reference
[1]. [Chinese Society of Clinical Oncology (CSCO) (2024)] Guidelines for the diagnosis and treatment of non-small cell lung cancer.
Experience the Future of AI-Powered Creativity! GIGABYTE AI PCs Lead You to Explore New Frontiers
TAIPEI, March 10, 2025 /PRNewswire/ — GIGABYTE, a global leader in high-performance computing, partners with the Taiwan Creative Content Agency (TAICCA) at SXSW 2025 XR Lounge, unveiling cutting-edge AI-driven solutions that push the boundaries of immersive content creation. Featuring advanced AI computing technology, GIGABYTE presents two groundbreaking experiences: VS AI Street Fighting Arcade and 4K 360 VR Video Editing Workflow, showcasing the capabilities of GIGABYTE AI PCs and their role in shaping the future of creative applications.
GIGABYTE Elevates Immersive Content with AI and XR at SXSW 2025
Game On: AI-Powered Real-Time Competition
GIGABYTE’s VS AI Arcade offers an interactive 1v1 gaming challenge, where players generate unique AI-driven artwork using text-to-image prompts in real time. Competitors bring their creativity to life with GIGABYTE AI PCs, powered by the Z790 AORUS MASTER motherboard and GeForce RTX 40 Series GPUs. The VS AI Arcade highlights GIGABYTE’s high-performance hardware in AI-enhanced gaming while showcasing how AI accelerates real-time content creation, transforming the gaming experience into an innovative and artistic challenge.
Next-Level AI Computing for Immersive Content Creation
For VR professionals, GIGABYTE introduces an 8K VR video editing workflow, featuring renowned creators Hugh Hou and Keeley Turner. Utilizing the TRX50 AERO D motherboard and GeForce RTX 4090 GAMING OC, this showcase demonstrates the next evolution of AI-powered video production, delivering seamless workflows and expanding creative possibilities in immersive media.
Key Highlights:
AI-Driven Workflow – Transforming 360 VR video editing with AI-powered enhancements.
Topaz Video AI Upscaling – Elevating lower-resolution footage to 8K clarity through AI-based video upscaling.
Real-Time Editing in Adobe Premiere Pro – Achieve seamless previewing and upscaling, powered by GIGABYTE AI PC performance.
As AI continues to revolutionize creative industries, GIGABYTE remains at the forefront, delivering cutting-edge hardware solutions that redefine gaming, content creation, and immersive experiences.
Visit us at SXSW 2025 XR Lounge, located in the “Sunflower” Ballroom at the Fairmont Austin, to explore how GIGABYTE AI PCs are shaping the next generation of AI-driven digital storytelling, immersive interaction, and creative workflows.
LONDON, ARMONK, N.Y. and MISSISSAUGA, ON, March 10, 2025 /PRNewswire/ — Mitsubishi Motor Sales of Canada announces an innovative AI-powered tool designed to transform the customer experience for the new Mitsubishi Outlander 2025. “The Intelligent Companion,” which launched on March 5, 2025, was created in collaboration with WongDoody (an Infosys company and IBM ecosystem partner) and leverages the IBM watsonx portfolio of AI products.
Leveraging IBM’s Granite model and trained on Mitsubishi Outlander 2025 data, this cutting-edge experience offers a personalized, interactive 3D visual guide to the vehicle’s features, enhancing customer engagement during the purchasing decision.
As a challenger brand, Mitsubishi Motors Canada is taking a focused approach to AI, investing in tools that can deliver real value to customers. “The Intelligent Companion” is the result of a first-time collaboration between Mitsubishi Motors Canada, WongDoody, and IBM.
This advanced tool offers a deep dive into AI-driven interactions, allowing users to explore the new Outlander in a real-world, Mitsubishi-branded environment. Developed by WongDoody, the 3D visualization within “The Intelligent Companion” showcases the vehicle’s features in an engaging and interactive way.
Unlike traditional brochure-ware, pre-set vehicle tours and legacy chatbots, “The Intelligent Companion” adapts to each customer, creating a personalized journey from vehicle-curious to vehicle-owner. It is built with IBM watsonx Orchestrate, a generative AI and automation solution for building, deploying and managing AI agents and assistants, and watsonx.ai, an integrated, end-to-end AI development studio. These tools enable it to handle large amounts of data and is designed to provide responses that feel natural and conversational.
Trained and rigorously tested with Canadian target audiences to ensure it addresses niche questions and use cases with incredible relevance and value, customers can ask any questions they have about the vehicle specific to their needs, making it a versatile, relevant, and engaging tool. Leveraging the innovative AI and automation capabilities of watsonx, “The Intelligent Companion” gives customers personalized guidance within a next-generation automotive buying experience.
Developed with a global team of AI and experience experts, the project moved from initial conversations to a proof of concept in just four weeks and was designed by WongDoody in collaboration with IBM Client Engineering and launched in market within an impressive twelve weeks—a testament to the speed and efficiency of WongDoody’s expertise and creative efficiency, alongside the flexibility of the watsonx technology.
Steve Carter, Marketing Director, Mitsubishi Motors Canada: “The Intelligent Companion” represents a major leap forward in customer engagement, offering a tailored experience that highlights the best features of the Mitsubishi Outlander 2025. Working with WongDoody and IBM has been an incredible collaboration, and we’re truly impressed by how quickly this innovation came to life. This tool perfectly aligns with our commitment to leveraging cutting-edge technology to enhance customer satisfaction and drive innovation across our brand.”
Ralf Gehrig, Global Chief Experience Officer, WongDoody: “Bringing this project to life at such speed and scale is a testament to the power of AI and global collaboration. With expertise from across the world, we combined technology and creative problem-solving to create something truly innovative in record time. This project proves that when the right minds and technology come together, the possibilities are endless.”
“With the watsonx portfolio, clients can swiftly and efficiently integrate generative AI into their operations, leveraging their own enterprise data to help enrich customer experiences and boost productivity for the enterprise. Solutions like watsonx Orchestrate and watsonx.ai are designed to scale and accelerate AI impact, empowering businesses to transform how they go to market and become AI-first organizations,” added Matt Sanchez, VP of product, watsonx Orchestrate at IBM.
About Mitsubishi Motor Sales of Canada, Inc.
Mitsubishi Motor Sales of Canada (MMSCAN) is the sales, service, parts and marketing arm for Japan’s Mitsubishi Motors. The 2025 product range includes the RVR subcompact crossover, Eclipse Cross compact sport utility and Outlander/Outlander PHEV compact sport utility. MMSCAN supports its 97 dealerships with a head office team and parts distribution centre, both located in Mississauga, Ontario. Established in 2002, MMSCAN and its dealerships employ more than 2,100 people in communities large and small.
IBM (NYSE: IBM) is a leading provider of global hybrid cloud, artificial intelligence, and consulting expertise. We help clients in over 175 countries harness insights from their data, optimize business processes, reduce costs and gain a competitive advantage in their industries. More than 4,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on the IBM hybrid cloud platform and Red Hat OpenShift to achieve their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in artificial intelligence, quantum computing, industry-specific cloud solutions and consulting offer open and flexible options to our clients. All of this is backed by IBM’s long-standing commitment to trust, transparency, accountability, inclusion and service. Visit www.ibm.com for more information.
IBM, the IBM logo, ibm.com and other marks belonging to IBM. IBM products and services are trademarks of the International Business Machines Corp., registered in many jurisdictions worldwide. A current list of IBM trademarks is available on the web at “Copyright and trademark information” at www.ibm.com/legal/copytrade.shtml.
About WongDoody:
WongDoody is the creative and technology agency from Infosys that creates intelligent marketing and experiences helping unlock what’s next for people and brands. With 22 studios and 2000+ employees around the globe, we serve clients in more than 55 countries with radically relevant human-centered creativity that solves business problems and transforms businesses through digital marketing that unlocks future potential with AI-driven marketing, data-backed strategies, intelligent products, services and platforms, virtual and augmented reality, digital twins, and next-gen AI content that people love. For more information https://www.wongdoody.com/ /